China NDRC Fines Two Pharmaceutical Distributors for Monopolistic Practice

By on November 21, 2011

by Henry L.T. Chen, Frank Schoneveld and Alex An

Recently,China’s National Development and Reform Commission (NDRC) imposed large fines on two pharmaceutical distributors.  This move indicates the enforcement agency, which supervises price-related monopolistic practices, is beginning to take a more active role in enforcing the country’s Anti-Monopoly Law.

To read the full article, click here

STAY CONNECTED

TOPICS

ARCHIVES